• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Intec Pharma Granted Patent in Hong Kong for Accordion Pill

July 19, 2017


Earlier today, Israel-based cannabinoid biotech company, Intec Pharma Ltd. (TASE:NTEC)(NASDAQ:NTEC) announced that the company has been granted a patent in Hong Kong for an accordion pill (the company's proprietary drug delivery technology) containing certain drugs including the combination of Carbidopa and Levodopa (one of Intec's non-cannabinoid products in developments). The patent is currently scheduled to remain in force until April 2029. 


Now Read: Inside Intec Pharma's Accordion Pill Technology


Management Response


Intec Pharma's CEO, Jeffrey A. Meckler


"We remain committed to building out our IN-7 patent family in order to fortify our global leadership in gastric retention drug delivery with the Accordion Pill technology platform and this patent further strengthens that position. This Hong Kong patent secures key elements of our Accordion Pill technology platform and our leading product, the Accordion Pill Carbidopa/Levodopa (AP-CD/LD), in significant markets. The AP-CD/LD is currently in a global Phase III clinical trial in advanced Parkinson's disease and the expanded patent protection will enhance any global commercial efforts for AP-CDLD."


Market Reaction


Shares of Intec Pharma trading on the Tel Aviv Stock Exchange closed today's session (prior to the news release) higher by 0.26% on the day. In midday North American trading, shares of Intec on the NASDAQ are rising more than 1.5% on light trading volume. Year-to-date, Intec shares on the Tel Aviv Stock Exchange are down roughly 4%


Now Read: Tel Aviv Listed Marijuana Stocks




For more information on Intec Pharma Ltd., be sure to check out the company's profile in our global marijuana stock database. Remember, the NASDAQ-listed shares of Intec can be traded commission free using the Robinhood app


Subscribe to one or more of our free e-mail newsletters (including our cannabinoid biotech and pharma newsletter) so you never miss an important cannabis stock update.


Also, don't forget to connect with The Daily Marijuana Observer on social media via FacebookTwitterStockTwits, and Instagram




Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.

Please reload

Please reload

Please reload


© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.